Aria Health Now Offers FDA-Approved Automated Breast Ultrasound System For Screening Women with Dense Breasts

Share Article

Invenia™ ABUS Clinically Proven to Increase Cancer Detection by 35.7%

News Image

Today, Aria Health, the largest healthcare provider in Northeast Philadelphia and Lower Bucks County, Pa., announced that its Breast Health program is on the leading edge of breast care with the addition of the Invenia™ Automated Breast Ultrasound System (ABUS) from GE Healthcare. Aria Health will be one of the few breast screening programs in the region with the Invenia™ ABUS – the only FDA ultrasound device approved for breast cancer screening in the United States as an adjunct to mammography for asymptomatic women with dense breast tissue and no prior interventions.

“This technology will significantly improve our ability to diagnose patients with dense breast tissue,” says Sonja Cerra-Gilch, MD, Section Chief of Breast Imaging and Intervention, Aria Health. “Our commitment has always been to provide our patients with the most advanced healthcare treatments possible and we are thrilled to be able to bring this technology to the Aria community.”

According to multiple large studies, dense breast tissue not only increases the risk of breast cancer up to four to six times, but it also increases the difficulty of detection of cancers through mammography. Several states, including Pennsylvania, have now passed laws requiring that women be notified if their breasts are dense, and may need additional imaging.

Ultrasound has become a key technology in breast cancer detection when added to mammography. Compared to traditional hand-held ultrasounds, the Invenia™ ABUS is made for breast screenings, and reduces operator and time dependency as it uses a wide transducer that automatically scans the breast to obtain volumetric image datasets. Routine hand-held ultrasounds are known for low reproducibility, require a highly trained operator and are not designed for breast screenings.

In conjunction with a mammogram, research shows that the ABUS technology has the potential to find 35.7 percent additional cancers that would not have been found with just a mammogram (FDA PMA Approval P110006, Sept. 18, 2012). Utilizing the ABUS, radiologists at Aria Health will quickly and safely be able to cull through hundreds of non-invasive breast tissue images to detect cancers that may have gone undetected.

To schedule an appointment, please call Aria Health’s Breast Health program at 215-831-5800.

About Aria Health:
Aria Health is the largest healthcare provider in Northeast Philadelphia and Lower Bucks County. With three leading-edge community hospitals and a strong network of outpatient centers and primary care physicians, Aria upholds a longstanding tradition of bringing advanced medicine and personal care to the many communities it serves. For more information about Aria Health please visit http://www.ariahealth.org “Like” Aria Health on Facebook at http://www.facebook.com/ariahealth and “Follow” Aria Health on Twitter at @AriaHealth.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Katy Rambo
Brian Communications
+1 (484) 385-2937
Email >